Overview

Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer

Status:
Terminated

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

Summary

To compare the efficacy of both strategies (reference treatment: Docetaxel+Prednisone and experimental treatment: Docetaxel+Estramustine+Hydrocortisone) by means of PSA values. To determine the time to treatment failure in both strategies To determine the overall and specific cause survival To evaluate the safety profile To analyze the Quality of Life

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Cortisol succinate
Docetaxel
Estramustine
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Prednisone